Unknown

Dataset Information

Establishing a robust radioligand therapy program: A practical approach for North American centers.


ABSTRACT: Radioligand therapy (RLT) is a targeted approach to treating cancer that has been shown to be safe and effective in a variety of disease states, including gastroenteropancreatic neuroendocrine tumors, lymphoma, and most recently, advanced prostate cancer. In the United States, patient access to this therapy is currently variable. Implementation of new RLT programs and expansion of existing programs are needed to broaden patient access to and standardize the delivery of RLT, especially as new therapies are introduced into clinical practice. Drawing from experience in establishing RLT programs in different settings, we have developed practical recommendations for building and implementing a robust RLT program. In this review, we present our recommendations for minimal requirements and optima

SUBMITTER: Mittra ES 

PROVIDER: S-EPMC10905220 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature